G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: A new player in cardiovascular and metabolic oestrogenic signalling

British Journal of Pharmacology

Volumn 163, Issue 6, 2011, Pages 1131-1139

  Nilsson, Bengt Olof ^a   Olde, Björn ^a   Leeb Lundberg, L M Fredrik ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cardiovascular regulation; cellular signalling; G protein coupled receptor; metabolic regulation; non genomic mechanisms; oestrogen

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G 1; G 15; G PROTEIN COUPLED RECEPTOR 30; HORMONE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; INSULIN RELEASE; MEAN ARTERIAL PRESSURE; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 79959768665     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01235.x     Document Type: Review

References (75)

1. Andersson, C, Lydrup, ML, Fernö, M, Idvall, I, Gustafsson, JA, Nilsson, BO, (2001). Immunocytochemical demonstration of estrogen receptor β in blood vessels of the female rat. J Endocrinol 169: 241-247. (Pubitemid 32451657)
2. Ariazi, EA, Brailoiu, E, Yerrum, S, Shupp, HA, Slifker, MJ, Cunliffe, HE, et al,. (2010). The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 70: 1184-1194.
3. Balhuizen, A, Kumar, R, Amisten, S, Lundquist, I, Salehi, A, (2010). Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Mol Cell Endocrinol 320: 16-24.
4. Barros, RP, Machado, UF, Gustafsson, JA, (2006). Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12: 425-431. (Pubitemid 44308462)
5. Bologa, CG, Revankar, CM, Young, SM, Edwards, BS, Arterburn, JB, Kiselyov, AS, et al,. (2006). Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2: 207-212.
6. Bonini, JA, Anderson, SM, Steiner, DF, (1997). Molecular cloning and tissue expression of a novel orphan G protein-coupled receptor from rat lung. Biochem Biophys Res Commun 234: 190-193. (Pubitemid 27267558)
7. Bopassa, JC, Eghbali, M, Toto, L, Stefani, E, (2010). A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298: H16-H23.
8. Brouchet, L, Krust, A, Dupont, S, Chambon, P, Bayard, F, Arnal, JF, (2001). Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103: 423-428. (Pubitemid 32105983)
9. Broughton, BR, Miller, AA, Sobey, CG, (2010). Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am J Physiol Heart Circ Physiol 298: H1055-H1061.
10. Brussaard, HE, Gevers Leuven, JA, Frolich, M, Kluft, C, Krans, HM, (1997). Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40: 843-849. (Pubitemid 27306964)
11. Carmeci, C, Thompson, DA, Ring, HZ, Francke, U, Weigel, RJ, (1997). Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45: 607-617. (Pubitemid 27506136)
12. Chambliss, KL, Wu, Q, Oltmann, S, Konaniah, ES, Umetani, M, Korach, KS, et al,. (2010). Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 120: 2319-2330.
13. Chen, Z, Yuhanna, IS, Galcheva-Gargova, Z, Karas, RH, Mendelsohn, ME, Shaul, PW, (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401-406. (Pubitemid 29069990)
14. Cornil, CA, Ball, GF, Balthazart, J, (2006). Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from? Brain Res 1126: 2-26. (Pubitemid 44889243)
15. Cruciani, RA, Dvorkin, B, Morris, SA, Crain, SM, Makman, MH, (1993). Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide-binding proteins in F-11 neuroblastoma-sensory neuron hybrid cells. Proc Natl Acad Sci U S A 90: 3019-3023. (Pubitemid 23113549)
16. Daaka, Y, Luttrell, LM, Lefkowitz, RJ, (1997). Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91. (Pubitemid 27494762)
17. Dennis, MK, Burai, R, Ramesh, C, Petrie, WK, Alcon, SN, Nayak, TK, et al,. (2009). In vivo effects of a GPR30 antagonist. Nat Chem Biol 5: 421-427.
18. Deschamps, AM, Murphy, E, (2009). Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am J Physiol Heart Circ Physiol 297: H1806-H1813.
19. Ding, Q, Gros, R, Limbird, LE, Chorazyczewski, J, Feldman, RD, (2009). Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30. Am J Physiol Cell Physiol 297: C1178-C1187.
20. Dragomir, E, Manduteanu, I, Calin, M, Gan, AM, Stan, D, Koenen, RR, et al,. (2008). High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells. Thromb Haemost 100: 1155-1165.
21. Feng Y, Gregor P, (1997). Cloning of a novel member of the G protein-coupled receptor family related to peptide receptors. Biochem Biophys Res Commun 231: 651-654. (Pubitemid 27217571)
22. Figtree GA, McDonald D, Watkins H, Channon KM, (2003). Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 107: 120-126. (Pubitemid 36070943)
23. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr, (2000). Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14: 1649-1660.
24. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI, (2002). Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16: 70-84. (Pubitemid 34044499)
25. Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, et al,. (2007). Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148: 3236-3245. (Pubitemid 46997004)
26. Filice E, Recchia AG, Pellegrino D, Angelone T, Maggiolini M, Cerra MC, (2009). A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat. J Physiol Pharmacol 60: 3-10.
27. Ford ES, Giles WH, Mokdad AH, (2004). Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27: 2444-2449. (Pubitemid 39281399)
28. Godsland IF, (2005). Oestrogens and insulin secretion. Diabetologia 48: 2213-2220. (Pubitemid 41618909)
29. Haas E, Bhattacharya I, Brailoiu E, Damjanovic M, Brailoiu GC, Gao X, et al,. (2009). Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity. Circ Res 104: 288-291.
30. Hall JM, Couse JF, Korach KS, (2001). The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872.
31. Hartge MM, Unger T, Kintscher U, (2007). The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 4: 84-88. (Pubitemid 47167491)
32. Holm A, Baldetorp B, Olde B, Leeb-Lundberg LMF, Nilsson BO, (2011). The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J Vasc Res 48: 327-335.
33. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N, (2008). Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 116: 1642-1647.
34. Isensee J, Meoli L, Zazzu V, Nabzdyk C, Witt H, Soewarto D, et al,. (2009). Expression pattern of Gpr30 in LacZ reporter mice. Endocrinology 150: 1722-1730.
35. Jessup JA, Lindsey SH, Wang H, Chappell MC, Groban L, (2010). Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats. PLoS ONE 5: e15433.
36. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, et al,. (2010). Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 24: 709-721.
37. Kvingedal AM, Smeland EB, (1996). A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett 407: 59-62. (Pubitemid 27174486)
38. Lawler OA, Miggin SM, Kinsella BT, (2001). Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling. J Biol Chem 276: 33596-33607.
39. Le May C, Chu K, Hu M, Ortega CS, Simpson ER, Korach KS, et al,. (2006). Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A 103: 9232-9237. (Pubitemid 43902561)
40. Li L, Haynes MP, Bender JR, (2003). Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci U S A 100: 4807-4812. (Pubitemid 36457810)
41. Lindner V, Sung KK, Karas RH, Kuiper GGJM, Gustafsson JA, Mendelsohn ME, (1998). Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 83: 224-229. (Pubitemid 28354468)
42. Lindsey SH, Cohen JA, Brosnihan KB, Gallagher PE, Chappell MC, (2009). Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 150: 3753-3758.
43. Liu S, Le May C, Wong WP, Ward RD, Clegg DJ, Marcelli M, et al,. (2009). Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58: 2292-2302.
44. Luo X, Zeng W, Xu X, Popov S, Davignon I, Wilkie TM, et al,. (1999). Alternate coupling of receptors to Gs and Gi in pancreatic and submandibular gland cells. J Biol Chem 274: 17684-17690.
45. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, et al,. (2004). The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279: 27008-27016. (Pubitemid 38812536)
46. Mamillapalli R, VanHouten J, Zawalich W, Wysolmerski J, (2008). Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem 283: 24435-24447.
47. MÃ¥rtensson UE, Salehi SA, Windahl S, Gomez MF, Swärd K, Daszkiewicz-Nilsson J, et al,. (2009). Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150: 687-698.
48. Martin NP, Whalen EJ, Zamah MA, Pierce KL, Lefkowitz RJ, (2004). PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. Cell Signal 16: 1397-1403. (Pubitemid 39277504)
49. Mendelsohn ME, Karas RH, (1999). The protective effects of estrogen on the cardiovascular system. New Engl J Med 340: 1801-1811. (Pubitemid 29266405)
50. Meyer MR, Baratella O, Prossnitz ER, Barton M, (2010). Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI182780. Pharmacology 86: 58-64.
51. Nadal A, Rovira JM, Laribi Q, Leon-Quinto T, Andreu E, Ripoll C, et al,. (1998). Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J 12: 1341-1348. (Pubitemid 28475575)
52. Nathan L, Pervin S, Singh R, Rosenfeld M, Chaudhuri G, (1999). Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo: possible mechanisms for gender differences in atherosclerosis. Circ Res 85: 377-385. (Pubitemid 29398870)
53. Nilsson BO, (2007). Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res 56: 269-273.
54. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, et al,. (2001). Mechanism of estrogen action. Physiol Rev 81: 1535-1565.
55. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, Heng HH, et al,. (1998). Discovery of three novel G-protein-coupled receptor genes. Genomics 47: 310-313. (Pubitemid 28086858)
56. Olde B, Leeb-Lundberg LMF, (2009). GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol Metab 20: 409-416.
57. Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, et al,. (2009). GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 80: 34-41.
58. Owman C, Blay P, Nilsson C, Lolait SJ, (1996). Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem Biophys Res Commun 228: 285-292. (Pubitemid 26396067)
59. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, et al,. (2002). Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 90: 1087-1092. (Pubitemid 34627907)
60. Patel VH, Chen J, Ramanjaneya M, Karteris E, Zachariades E, Thomas P, et al,. (2010). G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress. Int J Mol Med 26: 193-199.
61. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER, (2004). Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18: 2854-2865. (Pubitemid 39577911)
62. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signalling. Science 307: 1625-1630. (Pubitemid 40354745)
63. Ropero AB, Soria B, Nadal A, (2002). A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 16: 497-505. (Pubitemid 34214569)
64. Sidhu A, Sullivan M, Kohout T, Balen P, Fishman PH, (1991). D1 dopamine receptors can interact with both stimulatory and inhibitory guanine nucleotide binding proteins. J Neurochem 57: 1445-1451. (Pubitemid 21922774)
65. Stampfer M, Grodstein F, (1994). Cardioprotective effect of hormone replacement therapy. Is not due to selection bias. BMJ 309: 808-809. (Pubitemid 24291672)
66. Stevenson JC, Crook D, Godsland IF, Collins P, Whitehead MI, (1994). Hormone replacement therapy and the cardiovascular system. Nonlipid effects. Drugs 47 (Suppl. 2): 35-41.
67. Sutter-Dub MT, (2002). Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 67: 77-93.
68. Takada Y, Kato C, Kondo S, Korenaga R, Ando J, (1997). Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun 240: 737-741. (Pubitemid 28271788)
69. Takemoto M, Yokote K, Yamazaki M, Ridall AL, Butler WT, Matsumoto T, et al,. (1999). Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 258: 722-726. (Pubitemid 29290336)
70. Terasawa E, Noel SD, Keen KL, (2009). Rapid action of oestrogen in luteinising hormone-releasing hormone neurones: the role of GPR30. J Neuroendocrinol 21: 316-321.
71. Thomas P, Pang Y, Filardo EJ, Dong J, (2005). Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146: 624-632. (Pubitemid 40129818)
72. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, et al,. (2003). Estrogen receptor α mediates the brain anti-inflammatory activity of estradiol. Proc Natl Acad Sci U S A 100: 9614-9619. (Pubitemid 37033976)
73. Wang C, Dehghani B, Magrisso IJ, Rick EA, Bonhomme E, Cody DB, et al,. (2008). GPR30 contributes to estrogen-induced thymic atrophy. Mol Endocrinol 22: 636-648. (Pubitemid 351397791)
74. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, et al,. (2010). Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery 148: 436-443.
75. Windahl SH, Andersson N, Chagin AS, MÃ¥rtensson UE, Carlsten H, Olde B, et al,. (2009). The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am J Physiol 296: E490-E496.